Financial statements Biovena Health
Balance sheet data of BIOVENA HEALTH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 446 645,80 | 2 845 003,16 | 4 497 749,85 | 4 914 933,18 | 7 323 011,11 | 9 815 336,75 |
| A. Fixed assets | 274 183,05 | 162 942,93 | 548 251,77 | 523 117,71 | 1 099 566,70 | 4 098 889,25 |
| B. Current assets | 2 172 462,75 | 2 682 060,23 | 3 949 498,08 | 4 391 815,47 | 6 223 444,41 | 5 716 447,50 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 446 645,80 | 2 845 003,16 | 4 497 749,85 | 4 914 933,18 | 7 323 011,11 | 9 815 336,75 |
| A. Equity | 785 025,12 | 1 422 097,69 | 2 824 896,56 | 3 660 606,51 | 4 461 979,20 | 6 102 011,17 |
| B. Liabilities and provisions for liabilities | 1 661 620,68 | 1 422 905,47 | 1 672 853,29 | 1 254 326,67 | 2 861 031,91 | 3 713 325,58 |
| I. Long-term liabilities | 0,00 | 0,00 | 168 000,00 | 338 614,00 | 234 358,00 | 1 739 266,80 |
| II. Short-term liabilities | 1 510 425,81 | 1 395 159,11 | 1 492 889,51 | 915 712,67 | 2 626 673,91 | 1 974 058,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.